| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.68B | 14.62B | 14.48B | 13.53B | 13.30B | 17.71B |
| Gross Profit | 4.50B | 4.22B | 4.32B | 4.35B | 4.50B | 8.95B |
| EBITDA | 1.59B | 1.36B | 1.10B | 1.17B | 1.36B | 1.44B |
| Net Income | 2.38B | 623.68M | 145.41M | 595.77M | 716.87M | 693.95M |
Balance Sheet | ||||||
| Total Assets | 34.38B | 32.47B | 33.75B | 36.30B | 29.76B | 26.81B |
| Cash, Cash Equivalents and Short-Term Investments | 4.04B | 2.46B | 1.99B | 6.06B | 4.59B | 4.87B |
| Total Debt | 4.73B | 4.90B | 6.31B | 5.80B | 742.65M | 512.12M |
| Total Liabilities | 11.21B | 11.03B | 12.29B | 16.04B | 9.62B | 6.26B |
| Stockholders Equity | 23.16B | 21.45B | 21.46B | 20.26B | 20.14B | 20.55B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.25B | -4.65B | -3.91B | -109.35M | 1.04B |
| Operating Cash Flow | 0.00 | 2.33B | 90.17M | 45.00M | 1.13B | 1.51B |
| Investing Cash Flow | 0.00 | 635.72M | -4.08B | -3.13B | -1.19B | -165.18M |
| Financing Cash Flow | 0.00 | -2.49B | 31.18M | 4.57B | -413.76M | -774.13M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥132.03B | 6.86 | ― | 1.08% | 0.48% | -4.27% | |
72 Outperform | ¥1.48T | 18.60 | 11.19% | 1.46% | 2.65% | -5.76% | |
71 Outperform | ¥586.74B | 19.60 | 9.28% | 1.30% | 5.50% | 27.32% | |
68 Neutral | ¥24.21B | 4.38 | ― | 1.87% | 3.08% | -16.77% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥23.95B | 23.77 | ― | 2.05% | 0.99% | 830.67% | |
61 Neutral | ¥4.64T | 20.92 | 9.46% | 1.32% | 1.99% | -18.79% |